SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Dominguez Joseph

(Last) (First) (Middle)
10 S. DEARBORN STREET
54TH FLOOR

(Street)
CHICAGO IL 60603

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/01/2018
3. Issuer Name and Ticker or Trading Symbol
EXELON CORP [ EXC ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) X Other (specify below)
CEO, ComEd Effective 08/01/2018
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 0 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit Award (01/25/2016) (1) (1) Common Stock 3,711 $0 D
Restricted Stock Unit Award (01/30/2017 & 04/29/2017) (2) (2) Common Stock 7,473 $0 D
Restricted Stock Unit Award (01/29/2018) (3) (3) Common Stock 9,903 $0 D
Restricted Stock Unit Award (01/29/18) (4) (4) Common Stock 10,000 $0 D
NQ Stock Option (right to buy) 03/12/2012(5) 03/12/2016 03/12/2022 Common Stock 16,000 $39.81 D
NQ Stock Option (right to buy) 01/24/2011(5) 01/24/2015 01/24/2021 Common Stock 21,000 $43.4 D
NQ Stock Option (right to buy) 01/25/2010(5) 01/25/2014 01/24/2020 Common Stock 8,300 $46.09 D
NQ Stock Option (right to buy) 01/26/2009(5) 01/26/2013 01/26/2019 Common Stock 9,400 $56.51 D
Explanation of Responses:
1. Remaining 1/3 increment of annual restricted stock unit (RSU) award granted in 2016 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation & Leadership Development Committee's January meeting in the first, second and third years after the award was granted. Award balances accrue addtional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award.
2. Remaining 2/3 increments of RSU awards granted in January 2017 and April 2017 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation & Leadership Development Committee's January meeting in the first, second and third years after the award was granted. Award balances accrue addtional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award.
3. Annual RSU award granted in 2018 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation & Leadership Development Committee's January meeting in the first, second and third years after the award was granted. Award balances accrue addtional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award.
4. RSU award granted in 2018 pursuant to the Exelon Long Term Incentive Plan. Award to cliff-vest on January 29, 2020.
5. Fully-vested non-qualified employee stock option, awarded pursuant to the Exelon Long Term Incentive Plan. Each award vested in 1/4 increments on each of the first four anniversaries of the grant date, referenced in column 1.
Remarks:
Katherine A. Smith, Esq., Attorney-in-Fact for Joseph Dominguez 08/01/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.